𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

✍ Scribed by Jean-Claude Bystryn; Ruth Oratz; Matthew N. Harris; Daniel F. Roses; Frederick M. Golomb; James L. Speyer

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
624 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of patients with progressive u
Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine
✍ Ramon Vilella; Daniel Benitez; Jordi MilΓ ; Antoni Vilalta; Ramon Rull; Francisco πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 170 KB

## Abstract Unresectable metastatic melanoma has no elective treatment. Neither chemotherapy, intravenous IL‐2 nor biochemotherapy clearly improves the overall survival. Recent assays with therapeutic vaccines have been recently yielded promising results. Here, we describe the application, clinical

Endothelial-selectin ligands sialyl Lewi
Endothelial-selectin ligands sialyl Lewisx and sialyl Lewisa are differentiation antigens immunogenic in human melanoma
✍ Mepur H. Ravindranath; Amir A. Amiri; Philip M. Bauer; Mark C. Kelley; Richard E πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

the expression of sLe x and sLe a on the surface of normal melanocytes, melanoma cells from biopsies, and cell lines (M10-v, M24, and M101) constituting melanoma Sonya Valley Ghidossi Vaccine Laboratory, Labcell vaccine (MCV) were quantitated. Melanoma patients were immunized with oratory of Glycoli